Description Provide up-to-date technical and scientific support for complex biotechnology products; respond to product inquiries/requests, and contribute to the development and launch of new biotechnology solutions. $96,…
Skills: Cdna Cloning, Dna Transfection, Pcr, Western Blotting, Immunofluorescence
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
$97k–$100k/yr
Full-time
postgraduate degree
Posted 21d ago
~40 hrs/week
Responsibilities
Provide technical and scientific support for complex biotechnology products and respond to product inquiries. Contribute to the development and launch of new biotechnology solutions.
Requirements
Requires a Master's degree in Biotechnology or a related field. Must have demonstrated experience in molecular techniques, antibody-based research, and published scientific research.
Full job description
Description
Provide up-to-date technical and scientific support for complex biotechnology products; respond to product inquiries/requests, and contribute to the development and launch of new biotechnology solutions. $96,706.00 - $100,000.00/year.
Requirements
Master's degree or foreign equivalent in Biotechnology or a related field.
Must have demonstrated skills with molecular techniques, including cDNA cloning, DNA transfection, PCR; hands-on experience in antibody-based research applications such as Western, Immunofluorescence (IF)/Immunocytochemistry (ICC), and Flow; and publish scientific research involving microbial testing, assay development, and bioproduct stability studies.
Related keywords
BiotechnologyMolecular TechniquesCdna CloningDna TransfectionPcrWestern BlotImmunofluorescenceImmunocytochemistryFlow CytometryMicrobial TestingAssay DevelopmentBioproduct StabilityTechnical Support
OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome-wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.
OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 30,000 human full-length TrueClone cDNA collections and over 25,000 TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the largest offering of full-length human proteins expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB project to develop mouse monoclonal antibodies against protein antigens to develop protein assays for every human protein.
In addition, OriGene offers unique gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation
OriGene is committed to its mission to be “Your Gene Company”, supplying everything a researcher needs for gene-based research.
Visit us at https://www.origene.com
Offices: 9620 Medical Center Drive,, Suite 200, Rockville, MD 20850, US
Cancer pathologyExpression cDNA clonesFull-length human proteinsPrimary antibodiesMultiplex assaysGene synthesis ServiceAntibody and Protein Optimizationand Cancer tissue repository (Blocks/sections/RNA/DNA)Medical DeviceBiotechnology
OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome-wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.
OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 30,000 human full-length TrueClone cDNA collections and over 25,000 TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the largest offering of full-length human proteins expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB project to develop mouse monoclonal antibodies against protein antigens to develop protein assays for every human protein.
In addition, OriGene offers unique gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation
OriGene is committed to its mission to be “Your Gene Company”, supplying everything a researcher needs for gene-based research.
Visit us at https://www.origene.com
Offices: 9620 Medical Center Drive,, Suite 200, Rockville, MD 20850, US
Cancer pathologyExpression cDNA clonesFull-length human proteinsPrimary antibodiesMultiplex assaysGene synthesis ServiceAntibody and Protein Optimizationand Cancer tissue repository (Blocks/sections/RNA/DNA)Medical DeviceBiotechnology